287.04MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-06-18The current institutional shareholding score of Akebia Therapeutics Inc is 3.00, ranking 94 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 46.96%, representing a quarter-over-quarter increase of 1.21%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.68% of shares outstanding, with 0.48% decrease in holdings.
Institutional Shareholding
Shareholder Activity
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Geode Capital Management, L.L.C.
Alerce Investment Management, L.P.
Goldman Sachs & Company, Inc.
Qube Research & Technologies Ltd